Lv56
1528 积分 2020-07-27 加入
Bruton Tyrosine Kinase Degraders in B-Cell Malignancies
2小时前
已完结
Exploring the next generation of antibody–drug conjugates
17小时前
已完结
PROTAC targeted protein degraders: the past is prologue
1天前
已完结
First Results from a Phase 1, First-in-Human Study of the Bruton's Tyrosine Kinase (BTK) Degrader Bgb-16673 in Patients (Pts) with Relapsed or Refractory (R/R) B-Cell Malignancies (BGB-16673-101)
10天前
已完结
Resistance mechanisms and approach to chronic lymphocytic leukemia after BTK inhibitor therapy
10天前
已完结
BTK inhibitors and next-generation BTK-targeted therapeutics for B-cell malignancies
10天前
已完结
Effective degradation of EGFRL858R+T790M mutant proteins by CRBN-based PROTACs through both proteosome and autophagy/lysosome degradation systems
15天前
已完结
Journey of PROTAC: From Bench to Clinical Trial and Beyond
16天前
已完结
Targeting KAT6A/B as a New Therapeutic Strategy for Cancer Therapy
16天前
已完结
CDK2 and cyclin E knockout mice: lessons from breast cancer
16天前
已完结
皖公网安备34019202002308
